The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

drug cycling - one week on, one off

Mar 27, 2002

I recently read about a study where there was a great deal of success with patients who cycled their drugs weekly (one week on, one week off). This is attractive for two reasons: 1. I pay for a portion of my drugs and any savings is great. 2. I hate taking drugs.

Currently I am taking Viread, Epivir, and Virimune with a CD4 of 1200 and a VL less than 400.

Response from Dr. Boyle

The one week on/one week off study involved a very small number of patients on one antiretroviral regimen. It was relatively successful, and is being expanded to explore this treatment strategy further. It is premature to use this strategy at present, especially with the regimen you are on, which involves three drugs that may be one point mutation away from high-grade resistance, K65R, M184V and K103N/Y181C (among others) for Viread (tenofovir), Epivir (lamivudine) and Viramune (nevirapine), respectively.

Alcohol and meds
Your suggestions please on weight loss

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint